(Q52845850)
Statements
Intra-tumoral heterogeneity of KRAS and BRAF mutation status in patients with advanced colorectal cancer (aCRC) and cost-effectiveness of multiple sample testing. (English)
Susan D Richman
1 reference
Philip Chambers
Matthew T Seymour
Catherine Daly
Sophie Grant
Gemma Hemmings
1 January 2011
34
1-2
61-66
1 January 2011
1 reference